ETC Biomedical Systems Offers New FDA Cleared Hyperbaric Oxygen Therapy (HBOT) Medical Device


Southampton, PA, August 20, 2010 — Environmental Tectonics Corporation’s (OTC Bulletin Board: ETCC) (“ETC” or the “Company”) Biomedical Systems, a worldwide leader in the development, manufacture of computerized monoplace hyperbaric chambers, today confirmed that it has received FDA 510-k clearance for O.S.C.A.R. ™. O.S.C.A.R. ™ is an acronym for “Operating System for Control And Record Keeping”. This computerized system is configured as a stand-alone unit that will operate, control and record whole-body hyperbaric oxygen therapy treatments.
 
The FDA 510-k clears the way for the use of O.S.C.A.R. ™, the first stand alone computer hyperbaric oxygen control system intended for use as an ancillary device. The innovation behind O.S.C.A.R. ™ is a proprietary software system that allows hyperbaric technicians to program, manage, and reproduce the HBOT protocol time after time with the same accuracy of the first treatment. This proprietary software is included in each of our BARA-MED® computerized monoplace chambers.
 
ETC Biomedical Systems continues its evolution of offering unique and groundbreaking technology in the field of hyperbaric medicine. The O.S.C.A.R. ™ stand-alone system is a welcome addition to ETC’s long line of computerized commercial products in its portfolio
 
About ETC Biomedical Systems:
ETC Biomedical, is the world’s largest manufacturer of computerized monoplace hyperbaric chambers, with over 40 years of history and experience in the field of hyperbaric chamber technology beginning with the placement of our 1st hyperbaric chamber in 1971. Since ETC entered the clinical hyperbaric monoplace market in 1987, we have been a technology leader in the development of computerized hyperbaric chambers and systems. Further information on ETC’s hyperbaric products can be found at www.etchyperbaricchambers.com. The Biomedical Systems is a division of Environmental Tectonics Corporation. (www.etcusa.com)





Forward-looking Statements
This news release contains forward-looking statements, which are based on management's expectations and are subject to uncertainties and changes in circumstances. Words and expressions reflecting something other than historical fact are intended to identify forward-looking statements, and these statements may include terminology such as "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "future", "predict", "potential", "intend", or "continue", and similar expressions. We base our forward-looking statements on our current expectations and projections about future events or future financial performance. Our forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC and its subsidiaries that may cause actual results to be materially different from any future results implied by these forward-looking statements. We caution you not to place undue reliance on these forward-looking statements.

Latest News

November 27, 2024 ETC Announces Completion of Sales-Leaseback Transaction Generating $4.0 million in Working Capital

Read More